Evidence map›Paper›PMID 37035916›Full record

ArticleStroke2023

Iatrogenic Cerebral Amyloid Angiopathy Post Neurosurgery: Frequency, Clinical Profile, Radiological Features, and Outcome.

Kanishk Kaushik, Ellis S van Etten, Bob Siegerink, L Jaap Kappelle, Afina W Lemstra, Floris H B M Schreuder, Catharina J M Klijn, Wilco C Peul, Gisela M Terwindt, Marianne A A van Walderveen and 1 more

Abstract read
In one paragraph

Article in Stroke, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Iatrogenic cerebral amyloid angiopathy and cerebral amyloid angiopathy-related inflammation: clinical, radiological and biological findings from a case.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
  7. Article
  8. Observational
  9. Article
  10. Ethical considerations of disclosure of iatrogenic cerebral amyloid angiopathy.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  11. Article
  12. Clinical Management of Cerebral Amyloid Angiopathy.Journal of clinical medicine · 2025
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Cerebral amyloid angiopathy: a narrative review.Frontiers in aging neuroscience · 2025
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Kanishk KaushikDepartment of Neurology (K.K., E.S.v.E., G.M.T., M.J.H.W.), Leiden University Medical Center, the Netherlands.ORCID 0000-0003-1429-6853
Ellis S van EttenDepartment of Neurology (K.K., E.S.v.E., G.M.T., M.J.H.W.), Leiden University Medical Center, the Netherlands.ORCID 0000-0002-8301-6846
Bob SiegerinkDepartment of Clinical Epidemiology (B.S.), Leiden University Medical Center, the Netherlands.ORCID 0000-0002-8454-9142
L Jaap KappelleDepartment of Neurology, University Medical Center Utrecht, the Netherlands (L.J.K.).ORCID 0000-0001-8665-6630
Afina W LemstraDepartment of Neurology, Alzheimer center Amsterdam, Amsterdam University Medical Center, the Netherlands (A.W.L.).ORCID 0000-0002-8933-3260
Floris H B M SchreuderDepartment of Neurology, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, the Netherlands (F.H.B.M.S., C.J.M.K.).ORCID 0000-0002-7815-0207
Catharina J M KlijnDepartment of Neurology, Donders Institute for Brain, Cognition and Behavior, Radboud University Medical Center, the Netherlands (F.H.B.M.S., C.J.M.K.).ORCID 0000-0002-8495-4578
Wilco C PeulUniversity Neurosurgical Center Holland, LUMC|HMC|HAGA Leiden & The Hague, the Netherlands (W.C.P.).
Gisela M TerwindtDepartment of Neurology (K.K., E.S.v.E., G.M.T., M.J.H.W.), Leiden University Medical Center, the Netherlands.ORCID 0000-0003-3140-6882
Marianne A A van WalderveenDepartment of Radiology (M.A.A.v.W.), Leiden University Medical Center, the Netherlands.ORCID 0000-0003-4895-229X
Marieke J H WermerDepartment of Neurology (K.K., E.S.v.E., G.M.T., M.J.H.W.), Leiden University Medical Center, the Netherlands.ORCID 0000-0002-6838-9521

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrion-like transmission of amyloid-ß through cadaveric dura, decades after neurosurgical procedures, has been hypothesized as an iatrogenic cause of cerebral amyloid angiopathy (CAA). We investigated new and previously described patients to assess the clinical profile, radiological features, and outcome of this presumed iatrogenic CAA-subtype (iCAA).

methodsPatients were collected from our prospective lobar hemorrhage and CAA database (n=251) with patients presenting to our hospital between 2008 and 2022. In addition, we identified patients with iCAA from 2 other Dutch CAA-expertise hospitals and performed a systematic literature-search for previously described patients. We classified patients according to the previously proposed diagnostic criteria for iCAA, assessed clinical and radiological disease features, and calculated intracerebral hemorrhage (ICH)-recurrence rates. We evaluated the spatial colocalization of cadaveric dura placement and CAA-associated magnetic resonance imaging markers.

resultsWe included 49 patients (74% men, mean age 43 years [range, 27-84]); 15 from our database (6% [95% CI, 3%-10%]; 45% of patients <55 years), 3 from the 2 other CAA-expertise hospitals, and 31 from the literature. We classified 43% (n=21; 1 newly identified patient) as probable and 57% (n=28) as possible iCAA. Patients presented with lobar ICH (57%), transient focal neurological episodes (12%), or seizures (8%). ICH-recurrence rate in the new patients (16/100 person-years [95% CI, 7-32], median follow-up 18 months) was lower than in the previously described patients (77/100 person-years [95% CI, 59-99], median follow-up 18 months). One patient had a 10 year interlude without ICH-recurrence. We identified no clear spatial relationship between dura placement and CAA-associated magnetic resonance imaging markers. During follow-up (median, 18 months), 20% of the patients developed transient focal neurological episodes and 20% cognitively declined.

conclusionsiCAA seems common in patients presenting with nonhereditary CAA under the age of 55. Clinical and radiological features are comparable with sCAA. After diagnosis, multiple ICH-recurrences but also long symptom-free intervals can occur. Harmonized registries are necessary to identify and understand this potentially underrecognized CAA-subtype.

Indexed as

Cerebral Amyloid AngiopathyNeurosurgeryAdultCadaverCerebral HemorrhageFemaleHumansIatrogenic DiseaseMagnetic Resonance ImagingMaleNeurosurgical ProceduresProspective Studiesamyloidcerebral amyloid angiopathycerebral hemorrhagehuman growth hormonemagnetic resonance imagingneurosurgeryprions

Identifiers

PMID37035916
PMCPMC10121246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.